By Eleanor Garth – Logevity.Technology
Dr Alex Colville joins forces with Laura Deming to advance The Longevity Fund’s mission and lead investments in longevity science moonshots.
San Francisco-based age1, a venture capital firm catalyzing the next generation of founder-led longevity biotech companies, launched today to build a community of visionaries advancing new therapeutics, tools, and technologies targeting aging and age related disease.
